One-stop-shop drives Trust, Relevance, and Experience in this $100B+, 25%+ CAGR increasingly crowded and noisy sector
SAN FRANCISCO, November 24, 2020: Haynes and Boone, LLP and R&D Ribitzky jointly announce that they have formed a strategic alliance to counsel companies in the digital health and precision medicine sectors worldwide.
Both firms have deep, and unique experience serving these industry sectors and now offer an expanded scope of services for startups, investors, and corporate venture teams.
R&D Ribitzky and Haynes and Boone will share best practices across a range of business, clinical, technology, and legal opportunities, barriers, and strategies to high-growth companies and ecosystem clusters developing digital health and precision medicine products. As part of their new alliance, the two firms will co-produce webinars, podcasts, articles and other thought leadership tools that will explore cutting-edge topics and trends spanning business and market development strategies; intellectual property, finance, regulatory, and other legal issues; market data and intelligence; and case studies.
“This alliance allows us to leverage our respective skills and experience to offer digital health and precision medicine companies the breadth of services they need to bring their products to market and scale their businesses,” said Haynes and Boone Partner Jason Novak, who advises clients large and small on the various legal issues that arise with emerging technologies in the healthcare and life sciences industries.
“By teaming with Haynes and Boone, we provide a highly differentiated, highly efficient, and budget conscious one-stop shop for innovators, their financial backers, and ecosystem partners,” said Dr. Ron Ribitzky, founder and chief executive of R&D Ribitzky.
“This is a major addition of capabilities, resources, and market reach for our clients, and combined with the recently launched European Alliance for Technology Development we have formed in Paris, it provides entrepreneurs with unprecedented access to the experts required to help accelerate growth,” said Ray Solone, Senior Partner and Market Development Practice Lead at R&D Ribitzky.
About R&D Ribitzky
With offices in Boston, Washington D.C., San Francisco, Paris, and Singapore, R&D Ribitzky delivers cross-functional experts who bring together clinical and business, science and technology, digital experience and product development, marketing, sales, and ecosystem partners to its clients. R&D Ribitzky partners serve private and public-sector investors, startups and enterprise teams worldwide. For more information, please visit www.rdribitzky.com.
About Haynes and Boone, LLP
Haynes and Boone, LLP is an international corporate law firm with offices in Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services in energy, technology, financial services and private equity. With more than 575 lawyers, Haynes and Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It also was recognized across the board for excellence in the BTI Consulting Group’s 2020 “A-Team” report, which identifies the law firms that in-house counsel commends for providing superior client service.
The firm’s Precision Medicine and Digital Health Practice Group provides full-service counsel to the key players in precision medicine and digital health – from technology startups to established corporations, non-profit research institutions, universities, hospital systems, pharmaceuticals, and investors supporting the industry. Lawyers on team draw on the firm’s highly regarded healthcare, life sciences, technology and intellectual property experience to address trends in evolving markets, cutting-edge advances in technology, and legal and regulatory changes.
Contacts:
Raymond Solone
R&D Ribitzky
+1 916-521-5062
Elizabeth Elliott
Haynes and Boone, LLC
Elizabeth.Elliott@haynesboon.com
+1 949-202-3041
Copyright © 2023 R&D Ribitzky. All Rights Reserved.
Other brands & names belong to respective owners
By accepting our use of cookies, your data will be aggregated with all other user data.